Study In Asthma Control
NCT00273026 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 680
Last updated 2018-03-21
Summary
This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.
Conditions
Interventions
- DRUG
-
salmeterol xinafoate/fluticasone propionate
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-08
- Completion
- 2006-03-28
Countries
- Canada
Study Locations
More Related Trials
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
NCT04677959 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients
NCT00402948 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
NCT02127697 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication
NCT00577265 ·Status: COMPLETED
-
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
NCT01043276 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
NCT01823016 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
NCT02149199 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00603278 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
NCT02301975 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients
NCT03924635 ·Status: COMPLETED ·Phase: PHASE4
-
Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma
NCT02334553 ·Status: COMPLETED ·Phase: PHASE2
-
SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
NCT00290264 ·Status: COMPLETED ·Phase: PHASE3
-
SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults
NCT00259792 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma
NCT04503460 ·Status: UNKNOWN ·Phase: PHASE4
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT01647646 ·Status: COMPLETED ·Phase: PHASE4
-
Asthma Intervention Research (AIR) Trial
NCT00214526 ·Status: COMPLETED ·Phase: NA
-
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
NCT00102882 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
NCT02224157 ·Status: COMPLETED ·Phase: PHASE3
-
Atlantis Symbicort
NCT00646594 ·Status: COMPLETED ·Phase: PHASE3